Lincoln Capital LLC Boosts Position in Danaher Corporation $DHR

Lincoln Capital LLC increased its position in Danaher Corporation (NYSE:DHR) by 7.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 91,284 shares of the conglomerate’s stock after purchasing an additional 6,558 shares during the quarter. Danaher makes up 3.1% of Lincoln Capital LLC’s portfolio, making the stock its 7th biggest position. Lincoln Capital LLC’s holdings in Danaher were worth $17,388,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. JGP Wealth Management LLC boosted its stake in shares of Danaher by 7.6% in the 2nd quarter. JGP Wealth Management LLC now owns 4,620 shares of the conglomerate’s stock valued at $880,000 after purchasing an additional 327 shares during the last quarter. Dynamic Advisor Solutions LLC raised its stake in shares of Danaher by 35.6% during the second quarter. Dynamic Advisor Solutions LLC now owns 1,536 shares of the conglomerate’s stock worth $293,000 after buying an additional 403 shares during the last quarter. Baron Wealth Management LLC lifted its holdings in Danaher by 11.7% in the second quarter. Baron Wealth Management LLC now owns 2,971 shares of the conglomerate’s stock valued at $566,000 after buying an additional 312 shares during the period. GAMMA Investing LLC boosted its stake in Danaher by 24.4% in the second quarter. GAMMA Investing LLC now owns 12,380 shares of the conglomerate’s stock valued at $2,358,000 after acquiring an additional 2,426 shares during the last quarter. Finally, Central Pacific Bank Trust Division bought a new position in Danaher in the second quarter valued at approximately $38,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Price Performance

Shares of DHR stock opened at $199.52 on Thursday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The firm has a fifty day moving average of $189.84 and a 200-day moving average of $194.50. The firm has a market capitalization of $140.26 billion, a price-to-earnings ratio of 35.44, a price-to-earnings-growth ratio of 2.43 and a beta of 0.78.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter last year, the business posted $0.77 EPS. The firm’s revenue was up 5.5% compared to the same quarter last year. On average, equities research analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

Analyst Upgrades and Downgrades

DHR has been the subject of several recent research reports. Barclays dropped their target price on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Royal Bank Of Canada increased their target price on Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. DZ Bank initiated coverage on Danaher in a report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 target price on the stock. Finally, TD Cowen decreased their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.